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Introduction
Due to remarkable advances in the treatment of
 cancer, we have seen great improvements in long-
term survival rates of pediatric and reproductive-age
male patients (Steliarova-Foucher et al., 2004).
 Unfortunately, fertility in adult life may be severely
impaired by these treatments (Howell and Shalet,
1998; Brougham et al., 2003; Wallace et al., 2005).
For this reason, development of gonadal cryobiology
techniques is essential for fertility preservation.
Since the incidence of cancer is increasing at a
rate of 2% per year in adolescents and 1.1% in
 children (Stiller et al., 2006), and gonadotoxic
 treatments are also used to successfully treat benign
diseases such as drepanocytosis, thalassemia major,
aplastic anemia, nephrotic syndrome and systemic
autoimmune diseases, the population affected by
 fertility-threatening therapies is on the rise.
As a result of aggressive but effective chemo- and
radiotherapeutic intervention, between 70% and
80% of children with oncological diseases survive
their malignancies (Ries et al., 2004; Brenner et al.,
2007).
Although these treatments are highly effective, a
major concern is their adverse impact on fertility.
Currently available drugs to prevent testicular dam-
age from cytotoxic therapy have not proved helpful
in humans so far.  However, improved therapeutic
regimens using less gonadotoxic protocols (Kulkarni
et al., 1997; Radford et al., 1994; Tal et al., 2000)
could allow more patients to preserve their germ
stem cell pool and enable spontaneous recovery of
spermatogenesis. Unfortunately, use of these proto-
cols is not always possible without compromising
the chances of recovery from cancer.
Loss of fertility in adult life is a major and
 psychologically traumatic consequence (Schover et
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Abstract
Background: Recent advances in cancer therapy have resulted in an increased number of long-term cancer survivors.
Unfortunately, aggressive chemotherapy, radiotherapy and preparative regimens for bone marrow transplantation can
severely affect male germ cells, including spermatogonial stem cells (SSCs), and lead to permanent loss of fertility.
Different options for fertility preservation are dependent on the pubertal state of the patient.
Methods: Relevant studies were identified by an extensive Medline search of English and French language articles.
Results: Sperm cryopreservation prior to gonadotoxic treatment is a well established method after puberty. In case of
ejaculation failure by masturbation, assisted ejaculation methods or testicular tissue sampling should be considered.
Although no effective gonadoprotective drug is yet available for in vivo spermatogonial stem cell (SSC) protection in
humans, current evidence supports the feasibility of immature testicular tissue (ITT) cryopreservation. The different
cryopreservation protocols and available fertility restoration options from frozen tissue, i.e. cell suspension transplan-
tation, tissue grafting and in vitro maturation, are presented. Results obtained in humans are discussed in the light of
lessons learned from animal studies. 
Conclusion:Advances in reproductive technology have made fertility preservation a real possibility in young patients
whose gonadal function is threatened by gonadotoxic therapies. The putative indications for such techniques, as well
as their limitations according to disease, are outlined.
Key words: Fertility, chemotherapy, radiotherapy, cryopreservation, immature testicular tissue.
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al., 1999) and fertility preservation options should
therefore be proposed to these patients.
After puberty, cryopreservation of sperm is a well
established method of fertility preservation. For pre-
pubertal boys, however, very few options exist to
protect their fertility, besides choosing therapies that
are less toxic to their gonads. Advances in assisted
reproduction technologies (ART) and increasing in-
terest in in vivo and in vitro gamete maturation have
focused on preserving immature gametes and thus
germ stem cells before sterilizing treatments, in the
hope of developing new techniques allowing use of
stored immature gametes in the future.
Understanding the physiology of the testicular
stem cell, and the self-renewal and differentiation
events leading to the development of mature and
functional sperm cells, may help to elucidate the
 impact of chemotherapeutic drugs and radiation on
germ cells, as well as the potential options to
 decrease testicular damage and improve fertility
restoration approaches.
Thus, after first summarizing the physiology of
the testis, and the acute and long-term effects of
 cancer therapies on male fertility, this review will
 examine the current state of the art with respect to
male fertility preservation and restoration strategies.
Physiology of spermatogenesis
Spermatogenesis is a cyclic and continuous process,
with distinct phases: mitosis, meiosis and spermio-
genesis ongoing throughout the entire male life span.
It takes place within the seminiferous tubule, com-
posed of a basal membrane surrounded by a layer of
peritubular cells. The tubule contains seminiferous
epithelium populated by different types of germ
cells, according to pubertal state, and Sertoli cells,
playing a nursing role for the germ cells (Griswold,
1998) through secretion of various factors, such as
Glial cell line-derived neurotrophic factor (GDNF),
stem cell factor (SCF), Ets related molecule (ERM),
leukemia inhibitory factor (LIF) and bone morpho-
genetic protein 4 (BMP4). The number of functional
Sertoli cells determines final sperm production,
because the number of germ cells supported by the
Sertoli cells is finite (Orth et al., 1988).
Normal spermatogenesis relies on the presence of
an intact diploid spermatogonial stem cell (SSC)
 capable of self-renewal through mitotic amplifying
divisions, and differentiation involving two meiotic
divisions followed by maturation into haploid
 spermatids, the latter being transformed into
 spermatozoa. 
SSC homeostasis is regulated by intrinsic gene
 expression and extrinsic signals, including soluble
factors and adhesion molecules from the surrounding
microenvironment, known as the stem cell niche
(Ogawa et al., 2005). Diffusion of paracrine factors
secreted by interstitial Leydig cells or peritubular
myoid cells is also involved.
Study of SSCs has been hampered because of
their scarcity (0.03% of the total number of germ
cells in the adult mouse (Tegelenbosch and De Rooij,
1993)) and lack of specific markers for their isola-
tion, since SSCs are not morphologically different
from other spermatogonia, but are functionally dis-
tinct. However, culture systems that maintain a SSC
population for extended periods of time and allow
experimental modifications of added growth factors,
combined with transplantation assays demonstrating
their biological capacity to self-renew and differen-
tiate, have enhanced our understanding of the cellu-
lar and molecular characteristics of SSCs (Kubota et
al., 2004a, 2004b; Oatley and Brinster, 2006).
Spermatogenesis begins at puberty, although sper-
matogenic events leading to germ cell degeneration
before the haploid stage is reached already occur in
the prepubertal testis (Nistal and Paniagua, 1984).
Before puberty, the seminiferous tubule consists
of Sertoli cells and different types of spermatogonia,
including stem cells and differentiating type A and
type B spermatogonia (from the age of 4) (Nistal and
Paniagua, 1984). Two types of undifferentiated sper-
matogonia, in extensive contact with the basement
membrane, can be distinguished by morphological
criteria (Clermont, 1966): the type A dark spermato-
gonium functioning as a reserve stem cell which,
under normal conditions, is mitotically quiescent,
and the type A pale spermatogonium known as the
active stem cell, which through regular mitotic divi-
sions generates differentiating germ cells and also
maintains the stem cell population (Clermont, 1972).
Type B spermatogonia, characterized by chromatin
clumps in the nucleus and a centrally placed
 nucleolus, have the least contact with the basement
membrane and are committed to spermatogenic
 differentiation. Their number slowly increases until
the age of 8-9 years, after which a period of marked
spermatogonial proliferation occurs. When they
move into the core of the germinal epithelium and
are separated from neighboring cells by expansions
of Sertoli cells, they are known as preleptotene
 spermatocytes. Primary spermatocytes appear after
the last spermatogonial division and undergo the first
meiotic division at the beginning of puberty.
Spermarche, defined as the onset of sperm pro-
duction, occurs at a median age of 13.4 years (range:
11.7-15.2), when median testicular volume is
11.5 ml (range: 4.7-19.6). Most boys achieve
 spermarche prior to the age of peak height velocity
and before being able to produce an ejaculate
(Nielsen et al., 1986). In the absence of ejaculation,
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spermaturia, defined as the presence of sperm in the
urine, may be a useful tool to detect initiation of
spermatogenesis (Schaefer et al., 1990). 
Impact of gonadotoxic therapy on germ cells
Since rapidly dividing cells are the target of chemo-
and radiotherapy, these treatments act not only on
cancer cells, but also on germ cells during spermato-
genesis. Little is known about the effects of gonado-
toxic treatments on the immature testis, as fertility
cannot be assessed before puberty, but cytotoxic
damage to the testis has been extensively studied
after puberty.
Among the germ cells, differentiating spermato-
gonia proliferate the most actively and are thus
 extremely susceptible to cytotoxic agents, although
the less active stem cell pool may also be depleted
(Bucci and Meistrich, 1987).
As a result, the seminiferous epithelium becomes
damaged and the population of stem cells that
 normally differentiate to produce sperm after puberty
either becomes depleted or unable to differentiate,
leading to prolonged or even permanent azoospermia
due to destruction of the germ cells (for review, see
Schrader et al., 2001; Howell and Shalet, 2001). The
severity and duration of cytotoxic agent-induced
long-term impairment of spermatogenesis correlate
with the number of type A spermatogonia that are
destroyed (Meistrich, 1986), but remain unpre-
dictable because of variable individual sensitivities
(Naysmith et al., 1998).
After a cytotoxic insult, recovery of sperm
 production depends on the survival and ability of
 mitotically quiescent stem spermatogonia (type A
dark) to transform into actively dividing stem and
differentiating spermatogonia (type A pale) (van
Alphen et al., 1988). 
Gonadal impairment and fertility prognosis follow-
ing chemotherapy
Chemotherapeutic agents manifest their cytotoxic
 effect by interrupting essential cell processes such as
DNA synthesis and folate metabolism in rapidly
 dividing cells. 
Although the prepubertal testis does not complete
spermatogenesis, there is evidence that cytotoxic
treatment given to prepubertal boys may affect
 fertility (Rivkees and Crawford, 1988; Mackie et al.,
1996; Kenney et al., 2001). The presence of a steady
turnover of early germ cells that undergo sponta-
neous degeneration before the haploid stage is
reached (Muller and Skakkebaeck, 1983; Kelnar et
al., 2002) may explain why the prepubertal state
does not offer any protection against the deleterious
effects of chemotherapy.
The somatic compartment of the testis may be
more resistant to chemotherapeutic treatment, since
these cells have a low or absent mitotic rate. Never-
theless, increased concentrations of LH and symp-
tomatic reductions in testosterone concentrations
(Howell et al., 1999), both signs of Leydig cell im-
pairment, have been described, but the mechanism
of this impairment after chemotherapy is not known.
Evidence of Sertoli cell functional impairment
 following chemotherapy, responsible for germ cell
differentiation inhibition where germ cells have
 survived, have also been reported (Bar-Shira
 Maymon et al., 2004). 
The extent of damage is dependent on the agent
administered, the dose delivered, the combination of
cytotoxic drugs and the potential synergic interaction
of radiotherapy, which complicates identification of
the specific toxicity of each individual agent (for
 review, see Trottmann et al., 2007). Long-term
 fertility prognoses following treatment with different
chemotherapeutic agents used in childhood and best
estimates of fertility after chemotherapy for common
childhood cancers were recently updated (Wyns et
al., 2010).
Gonadal impairment and fertility prognosis follow-
ing radiation
Besides killing germ cells, including dividing
 spermatogonia and SSCs (de Rooij and Russel,
2000), radiotherapy causes a block in spermato -
gonial differentiation, which may be attributed to
damage to the somatic compartment (Zhang et al.,
2007). 
Radiation induces germinal depletion in a dose-
dependent manner (Rowley et al., 1974) and the
more immature cells are the most radiosensitive.
Doses as low as 0.1-1.2 Gy damage dividing sper-
matogonia and result in oligozoospermia. Radiation
doses over 4 Gy cause a more permanent detrimental
effect and may result in complete sterility.
Fractionated radiotherapy increases seminiferous
tubule damage, with doses greater than 1.2 Gy re-
sulting in permanent azoospermia (Ash, 1980). The
observed activation of reserve stem cells after a
gonadotoxic insult demonstrates that a single insult
is less damaging to the seminiferous epithelium than
multiple insults of lower intensity (Ash, 1980).
Testicular irradiation with doses above 20 Gy is
associated with Leydig cell dysfunction in prepuber-
tal boys, while Leydig cell function is usually pre-
served up to 30 Gy in adults (Shalet et al., 1989).
Apart from dose and fractionation, other factors
such as source, field of treatment, type of radiation,
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age and individual susceptibility influence the go-
nadotoxicity of irradiation.
Complete recovery of testicular function after ra-
diotherapy, evidenced by a return to pretreatment
numbers of spermatozoa, is dependent on the dose
administered. Indeed, it usually occurs within 9-
18 months following a dose of   1 Gy, 30 months
for 2-3 Gy and 5 years or more for doses of  4 Gy,
if sterility is not permanent (for review, see Howell
and Shalet, 2005).
Fertility preservation options
Three different approaches may be considered:
1. Minimizing testicular damage from cancer treat-
ment or protecting SSCs in vivo.
2. Cryopreserving sperm prior to gonadotoxic treat-
ment.
3. Cryopreserving testicular tissue prior to gonado-
toxic treatment in the form of either a cell
 suspension, tissue fragments or a whole organ.
In vivo SSC protection
Little is known about the mechanisms by which
 cancer treatment damages spermatogenesis,
 especially in the prepubertal testis, since tubular
damage cannot be evidenced before puberty. In order
to reduce the deleterious effects of gonadotoxic
 therapies, different strategies have been tested, such
as testicular shielding and use of cytoprotective
drugs.
Limiting radiation exposure by shielding or re-
moving the testes from the radiation field should be
implemented whenever possible (Wallace et al.,
2005; Ishiguro et al., 2007). 
Gonadal protection through hormonal suppression
is based on the principle that disruption of gameto-
genesis renders the gonads less sensitive to the
 effects of cytotoxic drugs or irradiation. Promising
results were obtained in rodents (for review, see
Shetty and Meistrich, 2005), but not in non-human
primates (Boekelheide et al., 2005) or humans
(Johnson et al., 1985; Waxman et al., 1987; Redman
and Bajorunas, 1987; Fossa et al., 1988; Kreuser et
al., 1990; Brennemann et al., 1994), except in one
clinical trial (Masala et al., 1997) where only mod-
erate stem cell death was induced by chemotherapy.
By contrast, stimulating spermatogonial proliferation
by FSH might be an option, as shown in monkeys
(van Alphen et al., 1989; Kamischke et al., 2003).
Anti-apoptotic agents such as sphingosine-1-
phosphate (Suomalainen et al., 2003; Otala et al.,
2004) and AS101 (Carmely et al., 2009), as well as
various other cytoprotective substances (Lirdi et al.,
2008; Okada et al., 2009), have also been used with
partial success in rodents.
In summary, no effective gonadoprotective drugs
are so far available for use in humans. Studies aimed
at identifying factors regulating spermatogonial pro-
liferation are therefore required to find novel targets
for in vivo SSC protection.
Sperm cryopreservation
General considerations
Cryopreservation of sperm is the only established
option for fertility preservation in postpubertal
males. It relies on the presence of spermatozoa and
the ability to ejaculate. This procedure has been per-
formed for decades (Royère et al., 1996) and it is
well known that spermatozoa survive long-term cry-
obanking. Indeed, their use through assisted repro-
duction techniques has led to the birth of healthy
offspring more than 20 years after initial storage
(Feldschuh et al., 2005).
Typically, it is recommended that 3 samples be
provided by masturbation, with 48-72 hours between
samples destined for freezing, regardless of semen
quality, as long as viable spermatozoa are available.
Indeed, since intracytoplasmic sperm injection
(ICSI) allows pregnancy even when a single viable
spermatozoon is available after thawing of frozen
semen (Hovatta et al., 1996), poor semen quality is
no longer a major concern for fertility preservation
in cancer patients. 
The care plan must nevertheless be individualized
according to patient status at diagnosis and time
available to collect an optimal number of samples.
Since sperm DNA integrity may be compromised
after cytotoxic treatment (Meistrich, 1993), it is
strongly recommended that sperm be cryopreserved
before initiation of chemotherapy or radiotherapy.
In case of failure to provide samples by mastur-
bation, assisted ejaculation techniques, such as
 penile vibratory stimulation or electroejaculation,
can be considered (Schmiegelow et al., 1998).
 Electroejaculation requires general anesthesia be-
cause of the pain induced by the procedure, so should
not be embarked upon without serious consideration.
Specific considerations for adolescent patients
If they are able or willing to ejaculate after mastur-
bation, sperm banking can be offered to all male
 adolescents newly diagnosed with cancer from
12 years of age (Bahadur et al., 2002). Reports on
male adolescent sperm cryopreservation showed that
the potential for fertility preservation in subjects as
young as 13 years of age was successful in about
50% of cases (for review, see Bashore, 2006).
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For physically mature patients, emotional imma-
turity may constitute a barrier to producing a sample
on demand, and appropriate counseling and educa-
tion should be available for these patients. Private
consultation with adolescents, allowing for questions
they may be uncomfortable asking in the presence
of their parents, has an important impact on the suc-
cess of sample collection (Bahadur et al., 2002).
Very little information is available on sperm
 quality in healthy adolescents. Specimens produced
are often of poor quality in peripubertal patients, as
many of them have only recently commenced
 spermarche. The time between the first clinical signs
of puberty and first ejaculation ranges between 8 and
12 months and early ejaculations are marked by very
small volumes, cryptozoospermia with a majority of
immotile spermatozoa, if not azoospermia, and
 abnormal liquefaction (Janczewski and Bablok,
1985). 
Cryopreservation of mature tissue
Cryopreservation of a testicular biopsy can be pro-
posed to patients who are not able to provide a
semen sample by masturbation or using an assisted
ejaculation procedure. In case of an azoospermic
sample, surgical retrieval of spermatozoa by TESE
(testicular sperm extraction) remains an option, since
it was shown that the procedure allows sperm re-
trieval in 50% of cases (Schrader et al., 2003). Cry-
opreservation methods for human spermatozoa
extracted from testicular biopsies have been imple-
mented for many years now (Hovatta et al., 1996).
Cryopreservation of immature tissue
Since prepubertal boys cannot benefit from sperm
banking, a potential alternative strategy for preserv-
ing their fertility involves immature testicular tissue
banking (for review, see Wyns et al., 2010). It is im-
portant to stress, however, that this strategy is still
experimental.
As prepubertal testicular tissue contains SSCs
from which haploid spermatozoa are ultimately de-
rived, these cells can either be cryopreserved as a cell
suspension (Brook et al., 2001) or in the form of tis-
sue (Kvist et al., 2006; Keros et al., 2007; Wyns et
al., 2007), in the hope that future technologies will
allow their safe utilization.
Cell suspensions
Cell suspensions have been developed with a view
to facilitating cryopreservation, as cell heterogeneity
in tissue pieces renders tissue freezing more chal-
lenging. Preparation of cell suspensions requires
mechanical and/or enzymatic digestion of tissue. The
risk of tissue digestion is that cell survival may be
compromised, as shown by the reduced viability of
suspensions after dispersion (Brook et al., 2001). In
addition, suppression of cell-to-cell interactions may
also be deleterious for cell proliferation and differ-
entiation (Griswold, 1998). 
Post-thaw viability ranging from 29% to 82% has
been reported after cryopreservation of testicular cell
suspensions in various animal models (Geens et al.,
2008).
Tissue pieces
Cryopreservation of testicular tissue pieces may be
considered as an alternative method suitable for
maintaining cell-to-cell contacts between Sertoli and
germinal stem cells, and therefore preserving the
stem cell niche necessary for their survival and
 subsequent maturation (Ogawa et al., 2005). Another
advantage of this method may be preservation of
the Sertoli cells, since there is evidence of their
 reversion to a dedifferentiated state as a consequence
of chemotherapy (Bar-Shira Maymon et al.,
2004).
Since tissue pieces also contain the interstitial
compartment, including Leydig cells, their preserva-
tion can be useful to alleviate the hormonal imbal-
ance caused by cytotoxic therapy (Howell and
Schalet, 2001). Better survival rates of Leydig cells
were obtained when DMSO was used (80% com-
pared to 50% with PROH) (Keros et al., 2005).
Structural integrity and functional capacity were
demonstrated after cryopreservation and culture of
fetal and prepubertal testicular tissue (Kvist et al.,
2006; Keros, 1999; Keros et al., 2007), as well as
after transplantation of cryopreserved fetal testicular
tissue (Grischenko et al., 1999).
Unlike cryopreservation of isolated cells, freezing
of tissue presents new problems because of the com-
plexity of tissue architecture. Protocols must strike
a balance between optimal conditions for each cel-
lular type, depending on water content, size and
shape of cells, and the water permeability coefficient
of their cytoplasmic membrane. In addition, prob-
lems can arise when extracellular ice forms, as it can
cleave tissues into fragments. Furthermore, rapid
solute penetration of highly compacted tissue is vital
to ensure high final concentrations of cryoprotectant
at temperatures which will minimize cytotoxicity.
These requirements necessitate optimization of
freeze-thawing protocols for each cell type, since
post-thaw survival and seminiferous tubule structure
are profoundly affected by both the type of cryopro-
tectant and the freezing rates (Milazzo et al., 2008).
DMSO, rather than EG, PROH or glycerol, was
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shown to better preserve structures within tissue
(Keros et al., 2005; Goossens et al., 2008a) and to
be best able to retain tissue capacity to initiate sper-
matogenesis (Jahnukainen et al. 2007). According to
Keros et al. (2007), use of slow-programmed freez-
ing is important to maintain undamaged morphology
of spermatogonia during tissue cryopreservation.
Two teams have reported freezing protocols for
prepubertal human testicular tissue that have yielded
good structural integrity (Kvist et al., 2006; Keros et
al., 2007). The second study investigated the
 influence of cryopreservation protocols on normal
immature human tissue (Keros et al., 2007). Besides
good tissue and cell integrity after freezing, very
good spermatogonial recovery was achieved with
their best protocol (94% ± 1% intact spermatogonia
after freeze-thawing and culture). This protocol,
 albeit slightly modified by the addition of sucrose,
was therefore used by our group for further evalua-
tion of the functional capacity of cryopreserved
human immature testicular tissue after xenografting
(Wyns et al., 2007, 2008). An overview of studies on
cryopreservation of immature testicular tissue is
 presented in Table I.  
Fertility restoration options
Fertility restoration after sperm cryopreservation
After thawing of cryopreserved semen samples, in-
trauterine insemination (IUI) may be considered, but
it depends on the survival of a sufficient number of
motile sperm to achieve good success rates. Due to
the possible deterioration of semen quality after sam-
ple thawing, the often unsatisfactory initial quality
of semen in cancer patients, and the limited sperm
reserve prior to therapy, IVF or IVF/ICSI are gener-
ally required to restore fertility in these patients. Suc-
cess rates of ART with cryopreserved sperm in male
cancer survivors are comparable to other indications,
and no significant increase in miscarriage or birth
defect rates has so far been reported after ART with
cryobanked semen from men with cancer (Sanger et
al., 1992; Agarwal et al., 2004).
Fertility restoration after mature tissue cryopreser-
vation
Use of spermatozoa from frozen testicular tissue
 requires assisted reproduction by ICSI. Healthy
pregnancies issuing from spermatozoa extracted
from cryopreserved testicular biopsies have been
reported for some time now and the technique is
widely used in clinical practice (Hovatta et al.,
1996).
Fertility restoration after immature tissue cryop-
reservation
Storage of testicular tissue could well be an option
for prepubertal boys. Indeed, besides diploid precur-
sor germ cells, some haploid germ cells may also be
found in their testes, since spermatogenesis is known
to occur to some extent in the testes of boys at very
early stages of pubertal development (Muller J. and
Skakkebaeck, 1983; Schaefer et al., 1990; Hovatta,
2001). In theory, and based on the reported fertiliza-
tion potential of early spermatids after microinjec-
tion into the egg (Tesarik et al., 1995), these haploid
spermatids obtained from the testes of prepubertal
boys may have reproductive potential, although this
has not yet been proved.
When haploid gametes are not present in their
testes, frozen diploid precursor cells provide some
hope of fertility restoration in these boys. To this end,
three approaches can be considered:
1. Transplantation of purified cell suspensions back
to their own testes.
2. Autografting of testicular pieces or whole testes.
3. In vitro maturation (IVM) up to the stage at
which they are competent for normal fertilization
through ICSI.
None of these approaches have been demonstrated
to be efficient and safe in humans as yet. These po-
tential options have mainly been studied in animals
and lessons learned from these studies will be re-
viewed in detail. 
Testicular germ cell transplantation
In this approach, spermatogenesis is reinitiated after
transplantation of isolated testicular stem cells in
germ cell-depleted testes. SSCs are recognized by
Sertoli cells and are relocated from the lumen onto
the basement membrane of seminiferous tubules.
Because stem cells have unlimited potential to self-
renew and produce differentiating daughter cells,
SSC transplantation offers the possibility of long-
term restoration of natural fertility. It could therefore
be a potential alternative to restore fertility after
cancer treatment.
The technique was first described in 1994 by Brin-
ster and Zimmermann, who developed a SSC assay
in mice that identified SSCs by their ability to gen-
erate a colony of spermatogenesis after transplanta-
tion. Testicular germ cells isolated from prepubertal
mouse testes were injected into the seminiferous
tubules of adult mice with Sertoli cell-only syndrome
induced by busulfan treatment (Brinster and Zim-
mermann, 1994). Normal donor spermatogenesis,
recognized by developing germ cells carrying the
94 F, V & V IN OBGYN
lacZ gene encoding b-galactosidase (evidenced his-
tochemically as an intracellular blue reaction), was
initiated and sustained (Fig. 1).
Although this approach has yielded healthy prog-
eny displaying the donor haplotype in animals (Brin-
ster and Avarbock 1994), it has not yet proved
successful in humans (see Progress towards human
clinical application).
Lessons learned from transplantation of fresh testic-
ular stem cells in animals
Outcome of the technique
Autologous SSC transplantation has been reported
in mice (Brinster and Zimmermann, 1994), rats
(Ogawa et al., 1999), pigs (Honaramooz et al.,
2002a; Mikkola et al., 2006), goats (Honaramooz et
al., 2003), cattle (Izadyar et al., 2003a), monkeys
(Schlatt et al., 2002a) and dogs (Kim et al., 2008).
Restoration of fertility from donor stem cells has
only been achieved in mice (Brinster and Avarbock,
1994; Ogawa et al., 2000; Nagano et al., 2001a;
Brinster et al., 2003; Goosens et al., 2003), rats
(Hamra et al., 2002; Ryu et al., 2003; Zhang et al.,
2003), goats (Honaramooz et al., 2003) and chickens
(Trefil et al., 2006).
Heterologous transplantation does not appear to
be as successful as autologous transplantation, prob-
ably because of the phylogenetic distance between
species. Indeed, it seems that the farther the phylo-
genetic distance, the less likely the transplantation is
to result in completion of spermatogenesis.
Table 1. — Overview of studies on cryopreservation of prepubertal human testicular tissue.
Reference Cryoprotec-
tant
(Non-)
controlled
Freezing rate Type of eval-
uation
Outcome
(germ cells)
Outcome
(endocrine compart-
ment)
Kvist et al.,
2006
EG1.5 M
Sucrose 0.1 M
Slow-
 controlled
Start: 1°C, -2°C/min to -9°C,
hold 5 min +
seeding, -0.3°C/min
to -40°C, -10°C/min to -140°C,
LN2
Culture
2 weeks
Well preserved STs
Presence of intact SG (c-
kit+)
Well preserved interstitial
cells
Testosterone and inhibin
levels similar to fresh
 tissue
Keros et al.,
2007
DMSO 0.7 M Slow-
 controlled
Program 1:
Start: 4°C, hold 30
min, -1°C/min to 0°C, hold 5
min, -0.5°C/min to -8°C, seed-
ing, hold 10 min, -0.5°C/min
to -40°C, hold 10 min, -7°C/min
to  -70°C, LN2
Culture
24 h
70 ± 7% ISTs in frozen-
cultured tissue (vs 71 ±
7% in fresh tissue and 77
± 4% in fresh-cultured
tissue)
94 ± 1% intact SG in
frozen-cultured tissue
(vs 93 ± 2% in fresh tis-
sue and 83 ± 1% in
fresh-cultured tissue)
Undamaged stromal struc-
ture: 80 ± 29% of frozen-
cultured samples
(vs 99.49 ± 0.88% of fresh
samples and 97 ± 2% of
fresh cultured samples)
Rapid- con-
trolled
Program 2:
Start: 4°C, hold 30
min, -1°C/min to -8°C, seeding,
hold 10 min, -10°C/min
to -80°C, LN2
20 ± 14% ISTs in
frozen-cultured tissue
50 ± 43% intact SG in
frozen-cultured tissue
Undamaged stromal struc-
ture: 29 ± 28% of frozen-
cultured samples
Wyns et al.,
2007
DMSO 0.7 M
Sucrose 0.1 M
Slow- con-
trolled
Start: 0°C, hold 9
min, -0.5°C/min to -8°C, hold 5
min + seeding, hold 15
min, -0.5°C/min to -40°C, hold
10 min, -7°C/min to -80°C,
LN2
Immediate
post-thaw
evaluation
0.71 ± 0.89 SG/ST in
frozen-thawed tissue (vs
0.45 ± 0.35 SG/ST in
fresh tissue)
Not assessed
Xenografting
3 weeks
82.19 ± 16.46% ISTs in
frozen-grafted tissue (vs
93.38 ± 6% in fresh tis-
sue)
14.5% SG recovery after
freezing and grafting
Wyns et al.,
2008
DMSO 0.7 M
Sucrose 0.1 M
Slow- con-
trolled
Start: 0°C, hold 9
min, -0.5°C/min to -8°C, hold 5
min + seeding, hold 15
min, -0.5°C/min to -40°C, hold
10 min, -7°C/min to -80°C,
LN2
Xenografting
6 months
55 ± 42% ISTs in
frozen-grafted tissue
3.7 ± 5.5% SG recovery
21% proliferating SG
Differentiation up to
pachytene stage of
prophase 
Signs of steroidogenic ac-
tivity by 3b-HSD IHC and
TEM
(I)ST: (intact) seminiferous tubule; SG: spermatogonia; LN2: liquid nitrogen; HSD: hydroxysteroid dehydrogenase; IHC: immunohistochemistry;
TEM: transmission electron microscopy.
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Indeed, SSCs from rabbits, dogs, pigs, bulls, stal-
lions, non-human primates and humans were able to
colonize the seminiferous tubules of mice and gen-
erate colonies of stem cells and cells that appeared
to be early differentiating daughter spermatogonia,
but could not differentiate beyond the stage of sper-
matogonial expansion (Dobrinski et al., 1999a;
Dobrinski et al., 2000; Oatley et al., 2002; Nagano
et al., 2001b; Hermann et al., 2007; Nagano et al.,
2002). This suggests that the initial steps of germ cell
recognition by Sertoli cells, migration to the base-
ment membrane and initiation of cell proliferation
are conserved among evolutionarily divergent
species.
Efficiency of the technique
The extent of spermatogenesis was shown to depend
on the number of transplanted stem cells, with an
almost linear correlation (Dobrinski et al., 1999b,
Fig. 2), and on the quantity and quality of stem cell
niches in the recipient testis (Ogawa et al., 2000).
In rodents, the observed colonization rate was no
higher than 1 out of 20 SSCs (Dobrinski et al.,
1999b), thus showing low colonization efficiency.
The colonization rate of slowly cycling primate type
A dark spermatogonia was expected to be much
lower (Jahnukainen et al., 2006a). Indeed, rhesus
SSC engraftment efficiency was estimated to be just
Fig. 1. — Procedure for testicular cell transplantation as developed in the mouse. 
(A) A single-cell suspension is prepared from the testes of a fertile male expressing a reporter transgene, Escherichia coli lacZ.
(B) The testicular cells can be cultured in appropriate conditions.
(C) Cells are microinjected into the seminiferous tubules of an infertile recipient male. There are three methods for microinjection: the
micropipette can be inserted (1) directly into the seminiferous tubules, (2) into the rete testis, or (3) into an efferent duct.
(D) Spermatogonial stem cells colonize the basement membrane of the tubules and generate donor cell-derived spermatogenesis, which
can be stained blue using a substrate for the reporter gene product (b-galactosidase). Each blue stretch of cells in the seminiferous
tubules of the recipient testis represents a spermatogenic colony derived from a single donor stem cell.
(E) Mating the recipient male with a wild-type female results in donor cell-derived spermatozoa fertilizing wild-type oocytes. 
(F) Progeny with the donor haplotype are produced. 
Source: Kubota and Brinster (2006) Nat Clin Pract Endocrinol Metab. 2 (2),99-108.
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0.0015%-0.003%, hence extremely low (Hermann et
al., 2007). Therefore, methods to increase coloniza-
tion efficiency need to be developed with a view to
effective clinical application.
Recipient age also appears to have an impact on
colonization efficiency (Shinohara et al., 2001). It
was suggested that the unique growth environment
of the immature testis could be the result of better
niche accessibility and niche proliferation due to Ser-
toli cell multiplication during testicular maturation
and growth, and/or factors facilitating colony forma-
tion, such as differences in hormones or growth fac-
tors. Moreover, the colony expansion may be
influenced by the increase in seminiferous tubule
length occurring with testicular enlargement. 
Techniques for SSC enrichment
Because of the small number of SSCs in a testis
(2/10,000 germ cells) (Muller and Skakkebaeck,
1983), the small size of testicular biopsies recovered
for fertility preservation, and the low efficiency of
recolonization after transplantation, development of
methods to increase the number of SSCs prior to
transplantation is essential. Ideally, isolation of pure
stem cells would be the most effective way of in-
creasing the number of SSCs in a suspension and
therefore transplantation efficiency (Shinohara et al.,
1999). Adequate purification will probably be best
achieved by cell sorting techniques, such as
 magnetic-activated cell sorting (MACS) or fluores-
cence-activated cell sorting (FACS) based on cell
characteristics and membrane antigens. Indeed, these
techniques have already been shown to improve
transplantation efficiency in mice. (Shinohara et al.,
1999, 2000, Ohta et al., 2000; Kubota et al., 2003,
2004a; Hofmann et al., 2005).As conserved expres-
sion of some markers of undifferentiated spermato-
gonia  exists between mice and non-human primates
(Hermann et al., 2007; 2009), there is hope that cell
enrichment techniques may be extended to humans.
Techniques for SSC expansion
Expansion of pure stem cells in culture appears to be
possible, although cell proliferation was found to
be limited (Hasthorpe, 2003). Better results were
achieved with expansion techniques using culture on
feeder layers with a combination of growth factors,
or applying serial transplantation procedures (Ogawa
et al., 2003; Kanatsu-Shinohara et al., 2003a).
Until recently, strategies for in vitro expansion of
SSCs had only proved successful in rodents
(Kanatsu-Shinohara et al., 2003a; Kubota et al.,
2004b; Ryu et al., 2005). Kanatsu-Shinohara et al.
(2003a) were able to culture neonatal mouse testic-
ular cells after supplementation of culture media
with various growth factors and hormones. After
Fig. 2.— Representative pattern of colonization of recipient testes by donor-derived spermatogenic cells three months after transplan-
tation of three different cell concentrations. A, B: Transplantation of 106 cells/ml. C, D: Transplantation of 107 cells/ml. E, F: Trans-
plantation of 108 cells/ml. A–F: Whole mount preparations of entire recipient testes stained with X-gal. Bar= 2 mm.
Source: Dobrinski et al. (1999), Mol Reprod Dev 53, 142-148.
A B C
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2 years, the cultured cells showed 1085-fold logarith-
mic proliferation, retaining characteristic morphol-
ogy and yielding fertile offspring after stem cell
transplantation (Kanatsu-Shinohara et al., 2005).
Long-term culture and propagation of human SSCs
has now also been reported (Sadri-Ardekani et al.,
2009).
Lessons learned from transplantation of frozen tes-
ticular stem cells in animals
Since high survival rates do not guarantee preserva-
tion of the functionality of frozen-thawed cells, it is
important to evaluate their capacity to self-renew and
differentiate through transplantation of cell suspen-
sions. Experiments on human germ cell transplanta-
tion were not able to achieve this goal since, after
6 months’ xenotransplantation to immunodeficient
mice, only proliferative activity was observed
(Nagano et al., 2002). Hence, studies in animals will
help us elucidate some important considerations to
be taken into account in the context of clinical ap-
plication.
The potential of frozen murine testicular cells to
resume spermatogenesis after transplantation was
demonstrated for the first time by Avarbock et al. in
1996. The birth of live offspring after transplantation
of frozen-thawed testicular cell suspensions provided
final proof of successful cryopreservation (Kanatsu-
Shinohara et al., 2003b). However, it appears that the
functional capacity of stem cells may be compro-
mised by cryopreservation (Frederickx et al., 2004).
By contrast, Kanatsu-Shinohara et al. (2003b) did
not observe decreased spermatogenic efficiency after
cryopreservation.
In addition, rhesus SSCs appear to retain normal
colonization capacity after freezing, since no sig -
nificant difference was found in the number of
produced colonies after frozen-thawed SSC trans-
plantation compared to fresh SSC transplantation in
mice (Hermann et al., 2007), suggesting that possi-
ble functional impairment involves germ cell differ-
entiation rather than their ability to recolonize stem
cell niches. 
Progress towards human clinical application
In humans, preclinical in vitro studies using cadaver
or surgically removed testes have demonstrated the
feasibility of transplanting germ cell suspensions
into testes. Fifty to 70% of seminiferous tubules
were filled by means of intratubular injection (Brook
et al., 2001) or injection into the rete testis, with nee-
dle placement controlled by ultrasonography (Schlatt
et al., 1999). The different injection techniques
described in the literature are shown in Fig. 3.
A clinical trial was initiated at the Christie
 Hospital in Manchester (UK) in 1999 to evaluate
germ cell transplantation in cancer patients.
 Testicular biopsies were obtained from adult males
with solid tumors and cryopreserved as single-cell
suspensions prior to cancer treatment. Five years
after the initial report, seven out of twelve patients
had undergone frozen-thawed germ cell transfer. As
far as we know, no information is available on the
fertility of these patients and follow-up is ongoing
(Radford 2003). Drawing conclusions from this trial
will nevertheless be problematic, as endogenous
spermatogenesis and spermatogenesis issuing from
transplanted cells will not be distinguishable.
Testicular tissue grafting
Testicular tissue grafting involves transplantation of
SSCs with their intact niches and thus within their
original microenvironment. Since testicular tissue
grafting has not yet been reported in humans, avail-
able data will be reviewed on the basis of observa-
tions made in animals.
To date, haploid germ cells isolated from mouse
testis homografts and rabbit testis xenografts have
been used with ICSI to produce offspring (Shinohara
et al., 2002; Schlatt et al., 2003; Ohta and
Wakayama, 2005). Xenogeneic rhesus sperm
 generated in host mice have also been shown to be
fertilization competent, allowing in vitro embryo
 development at a rate similar to that reported for in
situ rhesus testicular sperm (Honaramooz et al.,
2004). In view of these encouraging results in
Fig. 3.— Microinjection pipette insertion sites to introduce cell
suspensions into the seminiferous tubules.
A seminiferous tubule may be injected directly by inserting the
micropipette (-40 ~µm) into a straight stretch of the tubule (A),
into an efferent duct between the testis and the head of the epi-
didymis (B), or into the rete testis (C).
Source: Ogawa et al. (1997) Int. J. Dev. Biol (41): 111-122.
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 animals, there is every hope that it will be possible,
in the near future, to autograft cryopreserved testic-
ular tissue of patients rendered sterile after fertility-
threatening therapies and restore their fertility.
Lessons learned from transplantation of fresh testic-
ular tissue in animals
Grafting of testicular tissue from several mammalian
species into immunodeficient mouse hosts has re-
sulted in varying degrees of donor-derived spermato-
genesis. Complete spermatogenesis following
testicular grafting has been reported in mice, rabbits,
hamsters, pigs, goats, cats, bovines, horses and sheep
(Shinohara et al., 2002; Schlatt et al., 2002b, 2003;
Honaramooz et al.,2002b; Snedaker et al.,2004;
Zeng et al.,2006; Schmidt et al., 2006a; Oatley et al.,
2004, 2005; Ohta et al., 2005; Rathi et al., 2005,
2006; Arregui et al., 2008), as well as macaques
(Honaramooz et al., 2004; Rathi et al., 2008). By
contrast, germ cell differentiation blockage was ob-
served in marmosets (Schlatt et al., 2002b; Wistuba
et al., 2004, 2006; Jahnukainen et al., 2007).
The mechanisms underlying these species-spe-
cific discrepancies in spermatogenic differentiation
remain unknown. Differences between host and
donor gonadotropic hormones (Bousfield et al.,
1996), leading to inefficient interaction between
murine gonadotropins and grafted donor testicular
tissue (Rathi et al., 2008) as well as species-specific
structural variations in seminiferous tubule organi-
zation (Luetjens et al., 2005), resulting in modified
paracrine interactions (Honaramooz et al., 2004;
Wistuba et al., 2004), were suggested to be respon-
sible for these differences. Moreover, the stage of
germ cell development and intensity of spermato -
genesis at the time of grafting also appear to be in-
volved, since complete spermatogenesis was not
reported in xenografted tissue when donor testicular
tissue contained postmeiotic germ cells at the time
of grafting in any species, including humans (Geens
et al., 2006; Rathi et al., 2006; Schlatt et al., 2002b,
2006; C. Wyns, 2008, PhD thesis published by the
Catholic University of Louvain, Belgium).
The reasons for the poor outcome of adult testic-
ular tissue xenografting are so far unknown. How-
ever, studies in rodents have suggested that adult
tissue could be more sensitive to ischemia than im-
mature tissue, and that hypoxia related to the grafting
procedure may be involved (Schlatt et al., 2002b).
This hypothesis was supported by studies in bovines,
showing higher expression of some angiogenic fac-
tors in grafts from younger donors (Schmidt et al.,
2007). Furthermore, pretreatment of testicular tissue
with vascular endothelial growth factor (VEGF), a
potent angiogenic factor, was found to increase the
number of tubules containing elongating spermatids
(Schmidt et al., 2006b). 
Variations in Sertoli cell maturation at the time of
grafting, their developmental susceptibility to the
detrimental influence of endocrine disruption due to
the xenografting environment (Oatley et al., 2005;
Rathi et al., 2008), or donor age-dependent differen-
tial gene and subsequent protein expression in donor
tissue prior to grafting may also be implicated
(Schmidt et al., 2007).
Besides causing spermatogenic differentiation
 impairment, xenografting has been shown to be in-
efficient in some species. Indeed, only 5-10% of
seminiferous tubules in xenografts produced elon-
gated or elongating spermatids in bulls (Oatley et al.
2004, 2005; Schmidt et al., 2006a), kittens
(Snedaker et al., 2004) and horses (Rathi et al.,
2006). Furthermore, in non-human primate testicular
tissue grafts, only 2.8-4% of tubules contained
 mature sperm (Honaramooz et al., 2004; Rathi et al.,
2008). The reasons for this low spermatogenic
 efficiency need to be understood in order to improve
the success of this approach.
Initial germ cell loss, as reported in bovine and
monkey xenografts (Rathi et al., 2005, 2008), could
explain these poor results. Decreased expression of
GDNF, involved in germ cell self-renewal, has been
described in grafts (Schmidt et al., 2007), suggesting
that the grafting procedure itself could negatively in-
fluence the number of germ cells. However, tissue
culture performed prior to xenografting to increase
the number of SSCs did not result in a higher per-
centage of seminiferous tubules with elongating
spermatids at the time of graft removal (Schmidt et
al., 2006b), indicating that other factors may be
 responsible for the low spermatogenic efficiency.
Lessons learned from transplantation of frozen
 testicular tissue in animals
An overview of studies on cryopreserved testicular
tissue grafting in various animal models was recently
reported by Geens et al. (2008). In rodents,
 cryopreservation of ITT led to the birth of healthy
offspring (Shinohara et al., 2002). There is therefore
every hope that this approach can be extended to
 humans. 
A number of studies in animals designed to
 evaluate the effect of freezing on the functional
 capacity of germ cells have shown no impact on a
qualitative basis (Shinohara et al., 2002;
Honaramooz et al., 2002b; Schlatt et al., 2002b;
Ohta and Wakayama, 2005; Jahnukainen et al.,
2007; Goossens et al., 2008a; Van Saen et al., 2009).
Loss of SSCs after cryopreservation was neverthe-
less suggested, since Ohta and Wakayama (2005)
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 reported lower colonization efficiency after grafting
frozen-thawed testicular pieces.
Lessons learned from xenotransplantation of fresh
human testicular tissue
Very few studies have been published on xenotrans-
plantation of human testicular tissue (Geens et al.,
2006; Schlatt et al., 2006; Yu et al., 2006). Adult tes-
ticular tissue grafting has yielded poor results, show-
ing mainly sclerotic seminiferous tubules (and some
isolated spermatogonia in 21.6-23.1% of grafts)
(Geens et al., 2006; Schlatt et al., 2006).
Grafting of human ITT, either from fetuses (Yu et
al., 2006) or prepubertal boys (Goossens et al.,
2008b), did not result in complete spermatogenesis,
although graft and germ cell survival were shown to
be more favorable than in mature tissue grafts.
Goossens et al. (2008b) observed mainly Sertoli cell-
only tubules and just a few surviving spermatogonia
4 and 9 months after grafting, constituting consider-
able spermatogonial loss.
Lessons learned from xenotransplantation of frozen
human testicular tissue
No studies have reported xenografting of cryopre-
served adult testicular tissue and only two have been
published on cryopreserved ITT xenotransplantation
in humans (Wyns et al., 2007; 2008). Grafts were
performed orthotopically in immunodeficient mice.
After grafting frozen-thawed cryptorchid tissue for
3 weeks, we demonstrated survival of 14.5% of the
initial spermatogonial population, with 32 % of these
cells showing proliferative activity, not significantly
different from the 17.8% in fresh tissue. The number
of Sertoli cells was unchanged and 5.1% were pro-
liferative compared to 0% in fresh tissue. Raised
FSH levels in the castrated mice, the removal of
some inhibitory mechanisms that normally operate
in quiescent immature testes and/or other paracrine
factors were suggested to play a role in the Sertoli
cell multiplication. In order to study the capacity of
frozen SSCs to self-renew and differentiate, long-
term grafts of normal immature tissue were per-
formed. We found 3.7% of the initial spermatogonial
population remaining after freeze-thawing and
6 months’ xenografting, with 21% of these cells
showing proliferative activity.
Since considerable loss of spermatogonial cells
occurred, it was essential to evaluate to what extent
cryopreservation itself was implicated. Freezing did
not appear to have a major impact on these cells. In-
deed, no difference in spermatogonial cell numbers
was observed between fresh and frozen-thawed tes-
ticular pieces (Wyns et al., 2007) and high survival
rates (94 ± 1%) were obtained after freezing and
 culture (Keros et al., 2007). Regarding the effect of
cryopreservation on the differentiation capacity of
human SSCs, we found that the remaining spermato-
gonia retained the ability to reinitiate spermato -
genesis, but normal differentiation beyond the
prophase of the first meiosis could not be proved
with appropriate germ cell markers (Wyns et al.,
2008). We observed spermatid-like structures on
hematoxylin-eosin-stained histological sections
(Fig. 4), albeit slightly smaller than control sper-
matids (p = 0.045), but these structures did not show
characteristic markers of postmeiotic cells or acro-
some development by immunohistochemistry (IHC).
Preservation of the steroidogenic capacity of
 Leydig cells was evidenced by both IHC and trans-
mission electron microscopy (Wyns et al., 2008).
IVM of germ cells
IVM of germ stem cells, leading to in vitro-derived
male haploid gametes available for ICSI, circum-
vents the risk of reintroducing malignant cells,
 making this procedure potentially highly beneficial
in cancer patients.
Efforts have focused on establishing optimal in
vitro culture systems to allow male germ cells to
complete meiosis and spermatid elongation in exper-
imental conditions. So far, it has not been possible
to develop a culture system that supports complete
in vitro spermatogenesis from spermatogonia,
 despite several promising studies in animals (Lee et
al., 2001; Feng et al., 2002; Izadyar et al., 2003b).
A number of studies have investigated culture sys-
tems suitable for in vitro spermatogenesis in humans
(Cremades et al., 2001; Sousa et al., 2002; Tanaka
et al., 2003; Lee et al., 2007). Most studies describe
culture systems using Vero cells or Vero cell-condi-
tioned media (Cremades et al., 2001; Sousa et al.,
2002; Tanaka et al., 2003). Normally differentiated
elongated spermatids and even mature spermatozoa
able to fertilize human oocytes and achieve normal
embryonic development have been generated from
human round spermatids (Cremades et al., 2001).
The addition of Vero cell-conditioned medium to
a mixture of different types of spermatogonial cells
co-cultured with Sertoli cells, supplemented with
FSH and testosterone, induced differentiation of
human primary spermatocytes from non-obstructive
azoospermic men into round spermatids at a rate of
3-7%, and from round spermatids into normal late
spermatids at a rate of 5-32% (Sousa et al., 2002).
Co-culture of isolated primary spermatocytes with
Vero cells generated chromosomally normal round
spermatids (Tanaka et al., 2003).
Xenogeneic Sertoli cells were also used for IVM
of human male germ cells in co-culture, leading to
100 F, V & V IN OBGYN
the development of human round spermatids, but not
later stages of germ cell maturation (Kawamura et
al., 2003).
Encapsulation of testicular cells dissociated from
seminiferous tubules in calcium alginate, to promote
and sustain interactions between germ and Sertoli
cells without limiting permeability to media compo-
nents, was applied with limited success to human
testicular tissue from azoospermic males with
maturation arrest (Lee et al., 2006). Although this
method failed to induce spermiogenesis and did not
result in pregnancy, the differentiated germ cells
 displayed a normal chromosomal status and were
able to activate human oocytes after injection into
the cytoplasm.
In vitro culture of whole human testicular tissue,
allowing conservation of cellular interactions within
and between seminiferous tubules and the interstitial
compartment, was shown to elicit differentiation of
elongated spermatids from primary spermatocytes
when supplemented with rFSH and testosterone
(Tesarik et al., 1998), but gradual apoptotic loss of
meiotic and postmeiotic germ cells independent of
the presence of gonadotropins was reported (Roulet
et al., 2006).
To promote cell-to-cell communication, 3D cell
culture was developed, allowing re-establishment of
Sertoli and germ cell contacts within a collagen gel
matrix. The system led to differentiation of sperma-
tocytes from patients with maturational arrest into
presumptive spermatids (Lee et al., 2007).  
Induction of human meiosis and spermiogenesis
in an in vitro culture system represents an attractive
strategy for fertility restoration, which has yielded a
number of healthy live births (Tesarik et al., 1999),
but these were the result of maturation of the later
stages of spermatogenesis rather than the stem cells.
Since neither the biomolecular factors nor specific
microenvironment necessary for the development of
each stage of spermatogenesis have yet been com-
pletely elucidated, it is unlikely that IVM of diploid
stem cells into haploid spermatozoa will be techni-
cally feasible in the near future (Lee et al., 2006).
However, as germ cell survival and differentiation
appear to require co-culture with somatic cells,
 cryopreservation of tissue containing Sertoli cells
Fig. 4. — Histological appearance (hematoxylin/eosin sections) of donor testicular tissue from a 12-year-old boy after 6 months’
 orthotopic xenografting at 200 magnification (a), showing pachytene spermatocytes (arrow) and spermatid-like cells (inset) at
400 magnification (b) and spermatid-like cells at 1000 magnification (c).
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could be particularly useful with a view to potential
fertility restoration through IVM.
Safety issues
Cancer cell contamination
The most important, life-threatening concern of this
approach is the risk of reintroducing malignant cells
after transplantation. Indeed, the majority of pedi-
atric malignancies metastasize through the blood,
thus carrying a high risk of malignant contamination
of the testes. The risk is greater with hematological
cancers, as the testes can act as sanctuary sites for
leukemic cells. Indeed, it has already been shown
that as few as 20 leukemic cells injected into a testis
can induce a relapse of the disease (Jahnukainen et
al., 2001). Since reintroduction of malignant cells
into a patient previously cured of disease must be ab-
solutely excluded, germ cell isolation and cell sort-
ing methods allowing complete purification of SSCs
need to be validated before safe transplantation can
be contemplated. Cell sorting methods have shown
promising results in animal studies, as sorting of
murine germ cells allowed transplantation without
reinducing leukemia (Fujita et al., 2005). The tech-
nique was subsequently applied to human testicular
cell suspensions, but does not appear to have been
entirely successful (Fujita et al., 2006; Geens et al.,
2007). Table 2 summarizes existing studies on the
elimination of cancer cells from testicular cell sus-
pensions
Since no marker has yet been identified that is
exclusively expressed on SSCs, allowing positive
selection of these cells through cell sorting tech-
niques, further research into surface markers in ani-
mal germ cells and their equivalents in human germ
cells is needed to ensure complete elimination of
cancer cells from testicular cell suspensions. 
Cancer cell contamination is also a major concern
in tissue autografting, since it has been reported
that leukemic cells can survive cryopreservation/
xeno trans plantation (Hou et al., 2007). Therefore,
testicular tissue autografting after cure can only be
considered for patients in whom there is no risk of
testicular metastases or who have undergone
 gonadotoxic therapies for non-malignant disease.
Infectious transmission
Due to the risk of infectious transmission from ani-
mals to humans (Patience et al., 1998), testicular
xenografting should not be considered for reproduc-
tive purposes at present. This approach is neverthe-
less useful for the evaluation of the functional
capacity of germ cells and should therefore form part
of the assessment of germ cell cryopreservation pro-
tocols (Frederickx et al., 2004), for the understand-
ing of testicular physiology and pathophysiology
(Jahnukainen, 2006b) and for testing malignant
 contamination of tissue before autografting (Hou et
al., 2007).
The risk of animal viral transmission or contami-
nation with animal antigens or cellular membrane-
binding molecules (Patience et al., 1998) is also
present in IVM with co-culture systems using Vero
cells or xenogeneic Sertoli cells, so these systems
should not be used for clinical purposes.
Birth defect risks
Goossens et al. recently reported smaller litter size,
significantly lower fetal weight and reduced length
in first generation offspring after germ cell transplan-
tation, suggesting imprinting disorders (Goossens et
al., 2006). Further investigation is required to eluci-
date the underlying reasons before autotransplanta-
tion can be safely introduced into clinical practice. 
Apart from this study, very little information is avail-
able on potential birth defect risks after fertility
restoration techniques, and observations mainly
focus on IVM of diploid gametes. 
Chromosomal abnormalities were found in
 embryos obtained after ooplasmic injection of in
vitro-derived haploid germ cells issuing from diploid
germ cells in one study. These abnormalities could
be attributable to the completion of meiosis or part
of the spermiogenic process under in vitro condi-
tions, although the source of the immature tissue
used (men with non-obstructive azoospermia) may
also have played a role (Sousa et al., 2002).
Special attention should also be paid to the genetic
and epigenetic status of in vitro-matured cells
 (Bahadur et al., 2000; Bahadur, 2004). Indeed, ac-
celeration of the cytoplasmic and nuclear maturation
events that occur in vitro in cultured male germ cells
may override natural endogenous control mecha-
nisms involved in DNA condensation and cause a
disturbance in epigenetic reprogramming, resulting
in aberrant gene expression, abnormal phenotypic
characteristics and defects in the male gamete’s
 capacity to fertilize the oocyte and induce normal
embryonic development. 
In addition, abnormalities in the expression of
oocyte-activating factor or deficiencies in the func-
tioning of the reproducing element of the centrosome
of in vitro-derived haploid male gametes may cause
fertilization failure or aberrant embryonic develop-
ment after oocytoplasmic injection (for review, see
Georgiou et al., 2007).
Although the birth of healthy offspring has been
reported after IVM of immature germ cells like
 primary spermatocytes (Tesarik et al., 1999),
 insufficient data are currently available to allow safe
clinical application.
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Ethical concerns
Learning that a child has cancer is devastating for all
concerned, and treatment needs to begin quickly,
leaving very little time for the impact of possible
 future sterility to sink in. However, the inability to
father one’s own children might have a huge impact
on the psychological well-being of patients in adult-
hood (Schover, 2005; van den Berg et al., 2007), so
it is crucial to inform them of the potential conse-
quences of their therapy on future fertility. Ethical
concerns have been expressed about ITT cryopreser-
vation, highlighting the importance of the risk/ben-
efit balance (Bahadur and Ralph, 1999). Because of
the small size of testes from prepubertal children,
immature gonadal tissue sampling may be consid-
ered too invasive a procedure. However, in the two
existing studies on testicular tissue harvesting in
young cancer patients (Keros et al., 2007; Wyns et
al., 2007), no major surgical complications occurred
during testicular biopsy. Mean biopsy volume was
about 5% of testicular volume which, according to
morphological studies (Muller and Skakkebaeck,
1983), should provide enough germ cells for fertility
preservation. Regarding general anesthesia, since
this biopsy is generally performed under the same
anesthesia as that used for placement of the central
line for chemotherapy, there is no additional risk
 involved.
When considering the benefits of tissue harvest-
ing, the safety and effectiveness of fertility preser-
vation and restoration procedures are essential
issues.  Children and their parents should be informed
of the experimental nature of this approach and the
fact that there is no guarantee of success (Tournaye
et al., 2004; Bahadur, 2004; Jahnukainen et al.,
2006a). Parental consent and the child’s ascent,
meaning he was given the opportunity to discuss the
procedure, should be sought. As obtaining fully in-
formed consent from children is difficult, substituted
consent from parents should for now be limited to
the safekeeping of tissue (Bahadur and Ralph, 1999;
Bahadur et al., 2000).
With continued advances in potential fertility
restoration strategies, ethical guidelines will need to
be established with respect to harvesting, preserva-
tion and use of prepubertal testicular tissue.
Conclusion
Since post-therapy recovery of spermatogenesis
 remains unpredictable, it is important to inform
 patients facing infertility as a side effect of their
treatment of all the options available to preserve their
fertility (Wallace et al., 2005). Gamete banking
should be offered to all patients of reproductive age,
given the already well established and highly effec-
tive use of cryopreserved sperm and rapidly advanc-
ing experimental techniques allowing fertility
restoration after immature tissue banking in animals,
as well as the successes reported after ovarian tissue
cryopreservation and transplantation after recovery
from cancer.
Hormonal or cytoprotective drug manipulation
aimed at enhancing spontaneous recovery of
Table 2. — Studies on isolation of germ cells with detection of cancer cell contamination.
Reference Species Cell sorting
 technique
Markers Evaluation after cell sorting Outcome (% of residual
 contamination/number of
 contaminated samples or mice)
Fujita et
al., 2005
Mouse FACS H-2Kb/H2Db-
(MCH cl I)
CD45-
Cell transplantation
Histology: testis, bone marrow,
peritoneal exudate of recipient
mice
No contamination of recipient
mice
Fujita et
al., 2006
Human FACS MCH cl I -
CD45-
RT-PCR for germ cell markers
(DAZL, HIWI, VASA,
NANOG, STELLAR, OCT4)
1.45% K562 cells (CML)
0% K562 cells after IFg (for in-
duction of MCH cl I)
Geens et
al., 2007
Mouse MACS + FACS H2Kb- (MCH cl I)
CD49f+ (a6 integrin)
FACS 0.39% H2Kb+ cells
In vitro culture 3.1% (1/32) contaminated
 cultures
Cell transplantation 1/20 contaminated mice
Human FACS H2Kb- (MCH cl I) FACS
In vitro culture
PCR for B cell receptor
0.58% SB+ cells
1/11 contaminated samples
MCH cl I: major histocompatibility complex class I (marker of somatic cells); a6 integrin: marker of SSCs; CD45: surface marker
of leukemic cells; IFg: interferong; CML: chronic myelogenous leukemia.
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 spermatogenesis remains a possibility for the future.
SSC preservation offers the prospect of several real-
istic applications, although none is feasible in hu-
mans at this point in time. Future advances in fertility
preservation technology rely on improved under-
standing of the cryobiology of gonadal tissue and
cells.
Before considering fertility restoration options,
patient selection is essential, since risks vary accord-
ing to disease. No single (or simple) algorithm can
so far summarize all the possible strategies for fer-
tility preservation and restoration in case of gonado-
toxic therapy in male patients, but the most
appropriate course of action may be selected accord-
ing to the scheme shown in Figure 5. Over the next
few years, research should focus on how to extend
successful experiments in animals to young boys and
on the identification of the ideal microenvironment
for SSC development. As germ cell survival and dif-
ferentiation appear to require co-culture with somatic
cells, cryopreservation of tissue containing Sertoli
cells could be particularly useful with a view to
potential fertility restoration through IVM.
Resolving numerous important technical issues
discussed in this review should lead to safe and
 efficient methodologies for fertility restoration after
storage of ITT, and the development of ethically
 accepted pilot protocols, which will then need to be
submitted for further ethical approval before defini-
tive and universal clinical implementation. Until
then, samples should at least be banked after provid-
ing careful counseling and obtaining informed con-
sent, making sure the patient understands there is no
guarantee of success (Hovatta, 2003). Preservation
of testicular tissue from today’s prepubertal patients
will allow them to consider various fertility restora-
tion options that will emerge in the next 20-30 years,
giving them hope of fathering children with their
own genetic heritage. 
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